Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Leases (2019 - 2020)

Historic Current Leases for Akebia Therapeutics (AKBA) over the last 2 years, with Q1 2020 value amounting to $5.1 million.

  • Akebia Therapeutics' Current Leases fell 8372.09% to $5.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.1 million, marking a year-over-year decrease of 8372.09%. This contributed to the annual value of $5.0 million for FY2019, which is N/A changed from last year.
  • As of Q1 2020, Akebia Therapeutics' Current Leases stood at $5.1 million, which was down 8372.09% from $5.0 million recorded in Q4 2019.
  • In the past 5 years, Akebia Therapeutics' Current Leases registered a high of $31.3 million during Q1 2019, and its lowest value of $4.8 million during Q2 2019.